EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review

Filip Klausa, Natalia Świątoniowska-Lonc, Anna Skotny, Marek A Mak, Agnieszka Wysokińska-Kordybach, Jacek Skiba, Krzysztof Ściborski, Waldemar Banasiak iD, Adrian Doroszko iD

Journal of Clinical Medicine · 26.05.2026 · 15 (11) · 4113

DOI: 10.3390/jcm15114113 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.05.2026. Verfasst von Filip Klausa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid evolution of structural heart interventions, particularly transcatheter aortic valve implantation (TAVI), transcatheter edge-to-edge repair (TEER), and hybrid procedures, has significantly expanded treatment options for elderly, frail, and multimorbid patients previously considered high risk or inoperable. However, perioperative risk stratification in this population remains challenging. Traditional risk scores such as EuroSCORE, EuroSCORE II, STS-PROM, CHA2DS2-VASc, and HAS-BLED were developed and validated primarily in cohorts undergoing conventional open-heart surgery (CABG and surgical valve replacement) more than 15–25 years ago. This narrative review critically evaluates the performance and limitations of these classical models in contemporary populations undergoing modern structural cardiac interventions. Evidence from registries and meta-analyses indicates only moderate discriminatory ability and systematic calibration errors. EuroSCORE II and STS-PROM frequently overestimate risk in low- and intermediate-risk patients while underestimating it in high-risk and frail individuals, particularly regarding neurological, renal complications, and prolonged hospitalization. Similar limitations apply to CHA2DS2-VASc and HAS-BLED when used beyond their original scope in the peri-procedural setting of TAVI/TEER. The review highlights the growing role of frailty assessment, procedure-specific variables, and machine learning algorithms, which demonstrate superior predictive performance compared to conventional scores. Until dedicated, regularly updated risk models based on large TAVI/TEER registries become available, traditional scores should be used only as supportive tools within multidisciplinary Heart Team discussions that incorporate individual frailty, quality of life, and patient preferences.

Schlagwörter

Stichwörter der Autor:innen

frailtyheart valve prosthesis implantationrisk assessmenttranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
  • Department of Cardiology, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
  • Clinical Research Support Center, 4th Military Hospital, 50-981 Wroclaw, Poland.
  • Harvard T.H. Chan School of Public Health-Executive and Continuing Education, Harvard University, Boston, MA 02115, USA.
  • Clinical Department of Cardiology, Faculty of Medicine, Wroclaw University of Science and Technology, 50-981 Wroclaw, Poland.

ORCID-Profile: Waldemar Banasiak, Adrian Doroszko

Zitieren

APA

Klausa, F., Świątoniowska-Lonc, N., Skotny, A., Mak, M. A., Wysokińska-Kordybach, A., Skiba, J., Ściborski, K., Banasiak, W., & Doroszko, A. (2026). Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review. Journal of Clinical Medicine, 15(11), 4113. https://doi.org/10.3390/jcm15114113

Vancouver

Klausa F, Świątoniowska-Lonc N, Skotny A, Mak MA, Wysokińska-Kordybach A, Skiba J, et al. Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review. Journal of Clinical Medicine. 2026;15(11):4113. doi:10.3390/jcm15114113

BibTeX
@article{Klausa2026,
  author = {Klausa, Filip and Świątoniowska-Lonc, Natalia and Skotny, Anna and Mak, Marek A and Wysokińska-Kordybach, Agnieszka and Skiba, Jacek and Ściborski, Krzysztof and Banasiak, Waldemar and Doroszko, Adrian},
  title = {Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4113},
  doi = {10.3390/jcm15114113}
}
Kostenlos starten →